Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Immitec is a Norwegian life sciences company that develops and markets evidence-based nutritional supplements and health products. The company is widely recognized for its ImmiFlex brand, which incorporates patented beta-1,3/1,6-glucans to support and maintain a healthy immune system. Immitec collaborates with international ingredient partners to ensure high clinical standards and efficacy across its product range, which includes solutions for cardiovascular health, bone density, and general wellness. Headquartered in Tønsberg, the firm serves a global market with a strong presence in the Nordic region and the United Kingdom. The company emphasizes the use of clinically documented ingredients like Wellmune and MenaQ7.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Immitec.